vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and Dynatrace, Inc. (DT). Click either name above to swap in a different company.
Dynatrace, Inc. is the larger business by last-quarter revenue ($515.5M vs $359.9M, roughly 1.4× AdvanSix Inc.). Dynatrace, Inc. runs the higher net margin — 7.8% vs -0.8%, a 8.5% gap on every dollar of revenue. On growth, Dynatrace, Inc. posted the faster year-over-year revenue change (18.2% vs 9.4%). AdvanSix Inc. produced more free cash flow last quarter ($36.1M vs $27.2M). Over the past eight quarters, Dynatrace, Inc.'s revenue compounded faster (16.3% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Dynatrace, Inc. is an American multinational technology company that provides an AI-powered observability platform. Their software is used to monitor, analyze, and optimize application performance, software development, cyber security practices, IT infrastructure, and user experience.
ASIX vs DT — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $515.5M |
| Net Profit | $-2.8M | $40.1M |
| Gross Margin | 7.6% | 81.4% |
| Operating Margin | -0.7% | 14.1% |
| Net Margin | -0.8% | 7.8% |
| Revenue YoY | 9.4% | 18.2% |
| Net Profit YoY | -892.9% | -88.9% |
| EPS (diluted) | $-0.11 | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $515.5M | ||
| Q3 25 | $374.5M | $493.8M | ||
| Q2 25 | $410.0M | $477.3M | ||
| Q1 25 | $377.8M | $445.2M | ||
| Q4 24 | $329.1M | $436.2M | ||
| Q3 24 | $398.2M | $418.1M | ||
| Q2 24 | $453.5M | $399.2M | ||
| Q1 24 | $336.8M | $380.8M |
| Q4 25 | $-2.8M | $40.1M | ||
| Q3 25 | $-2.6M | $57.2M | ||
| Q2 25 | $31.4M | $48.0M | ||
| Q1 25 | $23.3M | $39.3M | ||
| Q4 24 | $352.0K | $361.8M | ||
| Q3 24 | $22.3M | $44.0M | ||
| Q2 24 | $38.9M | $38.6M | ||
| Q1 24 | $-17.4M | $37.9M |
| Q4 25 | 7.6% | 81.4% | ||
| Q3 25 | 6.8% | 81.8% | ||
| Q2 25 | 14.3% | 82.1% | ||
| Q1 25 | 14.2% | 80.9% | ||
| Q4 24 | 3.4% | 81.1% | ||
| Q3 24 | 14.4% | 81.4% | ||
| Q2 24 | 17.9% | 81.3% | ||
| Q1 24 | 0.9% | 81.1% |
| Q4 25 | -0.7% | 14.1% | ||
| Q3 25 | -0.9% | 14.8% | ||
| Q2 25 | 7.7% | 13.1% | ||
| Q1 25 | 7.7% | 9.6% | ||
| Q4 24 | -3.9% | 10.9% | ||
| Q3 24 | 7.5% | 11.2% | ||
| Q2 24 | 11.5% | 10.5% | ||
| Q1 24 | -7.0% | 6.1% |
| Q4 25 | -0.8% | 7.8% | ||
| Q3 25 | -0.7% | 11.6% | ||
| Q2 25 | 7.7% | 10.0% | ||
| Q1 25 | 6.2% | 8.8% | ||
| Q4 24 | 0.1% | 82.9% | ||
| Q3 24 | 5.6% | 10.5% | ||
| Q2 24 | 8.6% | 9.7% | ||
| Q1 24 | -5.2% | 10.0% |
| Q4 25 | $-0.11 | $0.13 | ||
| Q3 25 | $-0.10 | $0.19 | ||
| Q2 25 | $1.15 | $0.16 | ||
| Q1 25 | $0.86 | $0.12 | ||
| Q4 24 | $0.02 | $1.19 | ||
| Q3 24 | $0.82 | $0.15 | ||
| Q2 24 | $1.43 | $0.13 | ||
| Q1 24 | $-0.65 | $0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $1.2B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $2.7B |
| Total Assets | $1.7B | $4.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $1.2B | ||
| Q3 25 | $23.7M | $1.3B | ||
| Q2 25 | $18.4M | $1.3B | ||
| Q1 25 | $8.3M | $1.1B | ||
| Q4 24 | $19.6M | $1.0B | ||
| Q3 24 | $17.3M | $1.0B | ||
| Q2 24 | $12.1M | $1.0B | ||
| Q1 24 | $20.6M | $836.9M |
| Q4 25 | $815.2M | $2.7B | ||
| Q3 25 | $818.2M | $2.8B | ||
| Q2 25 | $823.7M | $2.7B | ||
| Q1 25 | $794.4M | $2.6B | ||
| Q4 24 | $774.6M | $2.6B | ||
| Q3 24 | $766.4M | $2.1B | ||
| Q2 24 | $746.6M | $2.1B | ||
| Q1 24 | $713.2M | $2.0B |
| Q4 25 | $1.7B | $4.1B | ||
| Q3 25 | $1.7B | $4.1B | ||
| Q2 25 | $1.6B | $4.1B | ||
| Q1 25 | $1.6B | $4.1B | ||
| Q4 24 | $1.6B | $3.7B | ||
| Q3 24 | $1.5B | $3.3B | ||
| Q2 24 | $1.5B | $3.3B | ||
| Q1 24 | $1.5B | $3.4B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $33.8M |
| Free Cash FlowOCF − Capex | $36.1M | $27.2M |
| FCF MarginFCF / Revenue | 10.0% | 5.3% |
| Capex IntensityCapex / Revenue | 7.7% | 1.3% |
| Cash ConversionOCF / Net Profit | — | 0.84× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $465.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $33.8M | ||
| Q3 25 | $26.6M | $32.0M | ||
| Q2 25 | $21.1M | $269.7M | ||
| Q1 25 | $11.4M | $162.8M | ||
| Q4 24 | $64.2M | $42.2M | ||
| Q3 24 | $57.3M | $23.6M | ||
| Q2 24 | $50.2M | $230.7M | ||
| Q1 24 | $-36.2M | $131.7M |
| Q4 25 | $36.1M | $27.2M | ||
| Q3 25 | $66.0K | $27.8M | ||
| Q2 25 | $-7.2M | $262.2M | ||
| Q1 25 | $-22.6M | $148.2M | ||
| Q4 24 | $29.8M | $37.6M | ||
| Q3 24 | $26.8M | $20.1M | ||
| Q2 24 | $16.7M | $227.4M | ||
| Q1 24 | $-71.6M | $121.9M |
| Q4 25 | 10.0% | 5.3% | ||
| Q3 25 | 0.0% | 5.6% | ||
| Q2 25 | -1.7% | 54.9% | ||
| Q1 25 | -6.0% | 33.3% | ||
| Q4 24 | 9.1% | 8.6% | ||
| Q3 24 | 6.7% | 4.8% | ||
| Q2 24 | 3.7% | 57.0% | ||
| Q1 24 | -21.3% | 32.0% |
| Q4 25 | 7.7% | 1.3% | ||
| Q3 25 | 7.1% | 0.8% | ||
| Q2 25 | 6.9% | 1.6% | ||
| Q1 25 | 9.0% | 3.3% | ||
| Q4 24 | 10.4% | 1.1% | ||
| Q3 24 | 7.7% | 0.8% | ||
| Q2 24 | 7.4% | 0.8% | ||
| Q1 24 | 10.5% | 2.6% |
| Q4 25 | — | 0.84× | ||
| Q3 25 | — | 0.56× | ||
| Q2 25 | 0.67× | 5.62× | ||
| Q1 25 | 0.49× | 4.14× | ||
| Q4 24 | 182.29× | 0.12× | ||
| Q3 24 | 2.57× | 0.54× | ||
| Q2 24 | 1.29× | 5.97× | ||
| Q1 24 | — | 3.47× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
DT
| Subscription And Circulation | $493.4M | 96% |
| Services | $22.1M | 4% |
